On November 5, 2020 Inhibrx, Inc. (Nasdaq: INBX), a clinical-stage biotechnology company focused on developing a broad pipeline of novel biologic therapeutic candidates, reported that the Company will be presenting at the following upcoming virtual investor and scientific conferences (Press release, Inhibrx, NOV 5, 2020, View Source [SID1234570216]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The 29th Annual Credit Suisse Virtual Healthcare Conference; Thursday, November 12th at 3:30 p.m. Eastern Time;

Jefferies Virtual London Healthcare Conference; Tuesday, November 17th at 2:10 p.m. Eastern Time;
CTOS 2020 Virtual Annual Meeting; Friday, November 20th at 9:00 a.m. Eastern Time; and

Evercore’s Annual Conference; Thursday, December 3rd at 3:30 p.m. Eastern Time
Each investor conference presentation will be webcast live and may be accessed through a link on the investors section of Inhibrx’s website at View Source The webcasts will be available for 60 days following the events.